Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS

NCT00142987 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00142987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00142987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Tegaserod in Relieving the Symptoms of Female Patients With Irritable Bowel Syndrome (IBS), Excluding Those With Predominant Diarrhea IBS
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2004
Completion date
June 30, 2005
Enrollment
664
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ibs-c and ibs with mixed bowel habits